Short-duration oral terbinafine for the treatment of tinea pedis in HIV-positive patients.

Cutis; cutaneous medicine for the practitioner

Volumn 68, Issue 1 Suppl, 2001, Pages 30-39

  Smith, S ^a   Houpt, K ^a   Rich, P ^a   LaMarca, A ^a   Weinberg, J M ^a   Alferez, T S ^a   Atillasoy, E ^a   Opper, C ^a  

^a San Diego   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; NAPHTHALENE DERIVATIVE; TERBINAFINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOLOGY; MALE; MIDDLE AGED; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; TIME; TINEA PEDIS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; AGED; ANTIFUNGAL AGENTS; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; NAPHTHALENES; TIME FACTORS; TINEA PEDIS; TREATMENT OUTCOME;

EID: 0035409633     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)